Comparison of dysferlin expression in human skeletal muscle with that in monocytes for the diagnosis of dysferlin myopathy

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Gallardo, Eduard ^a   de Luna, Noemi ^a   Diaz Manera, Jordi ^a   Rojas García, Ricardo ^a   Gonzalez Quereda, Lidia ^a   Flix, Bàrbara ^a   de Morrée, Antoine ^b   van der Maarel, Silvère ^b   Illa, Isabel ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DYSFERLIN; CD14 ANTIGEN; DYSF PROTEIN, HUMAN; MEMBRANE PROTEIN; MUSCLE PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DYSFERLIN GENE; DYSFERLIN MYOPATHY; FEMALE; GENE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MONOCYTE; MUSCLE BIOPSY; MUTATIONAL ANALYSIS; MYOPATHY; PRESCHOOL CHILD; PROTEIN EXPRESSION; SKELETAL MUSCLE; WESTERN BLOTTING; BIOPSY; COMPARATIVE STUDY; DYSFERLINOPATHY; GENETICS; LIMB GIRDLE MUSCULAR DYSTROPHY; METABOLISM; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; SOLUBILITY;

ADULT; ANTIGENS, CD14; BIOPSY; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; MALE; MEMBRANE PROTEINS; MONOCYTES; MUSCLE PROTEINS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES, LIMB-GIRDLE; MUTATION; SOLUBILITY;

EID: 83455262487     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029061     Document Type: Article

References (38)

1. Bashir R, Britton S, Strachan T, Keers S, Vafiadaki E, et al. (1998) A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nat Genet 20: 37-42.
2. Liu J, Aoki M, Illa I, Wu C, Fardeau M, et al. (1998) Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet 20: 31-36.
3. Illa I, De Luna N, Dominguez-Perles R, Rojas-Garcia R, Paradas C, et al. (2007) Symptomatic dysferlin gene mutation carriers: characterization of two cases. Neurology 68: 1284-1289.
4. Illa I, Serrano-Munuera C, Gallardo E, Lasa A, Rojas-Garcia R, et al. (2001) Distal anterior compartment myopathy: a dysferlin mutation causing a new muscular dystrophy phenotype. Ann Neurol 49: 130-134.
5. Klinge L, Dean AF, Kress W, Dixon P, Charlton R, et al. (2008) Late onset in dysferlinopathy widens the clinical spectrum. Neuromuscul Disord 18: 288-290.
6. Nguyen K, Bassez G, Krahn M, Bernard R, Laforet P, et al. (2007) Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes. Arch Neurol 64: 1176-1182.
7. Okahashi S, Ogawa G, Suzuki M, Ogata K, Nishino I, et al. (2008) Asymptomatic sporadic dysferlinopathy presenting with elevation of serum creatine kinase. Typical distribution of muscle involvement shown by MRI but not by CT. Intern Med 47: 305-307.
8. Urtizberea JA, Bassez G, Leturcq F, Nguyen K, Krahn M, et al. (2008) Dysferlinopathies. Neurol India 56: 289-297.
9. Vilchez JJ, Gallano P, Gallardo E, Lasa A, Rojas-Garcia R, et al. (2005) Identification of a novel founder mutation in the DYSF gene causing clinical variability in the Spanish population. Arch Neurol 62: 1256-1259.
10. Paradas C, Gonzalez-Quereda L, De Luna N, Gallardo E, Garcia-Consuegra I, et al. (2009) A new phenotype of dysferlinopathy with congenital onset. Neuromuscul Disord 19: 21-25.
11. Paradas C, Llauger J, Diaz-Manera J, Rojas-Garcia R, De Luna N, et al. (2010) Redefining dysferlinopathy phenotypes based on clinical findings and muscle imaging studies. Neurology 75: 316-323.
12. Ho M, Gallardo E, McKenna-Yasek D, De Luna N, Illa I, et al. (2002) A novel, blood-based diagnostic assay for limb girdle muscular dystrophy 2B and Miyoshi myopathy. Ann Neurol 51: 129-133.
13. Wein N, Krahn M, Courrier S, Bartoli M, Salort-Campana E, et al. (2010) Immunolabelling and flow cytometry as new tools to explore dysferlinopathies. Neuromuscul Disord 20: 57-60.
14. Lo HP, Cooper ST, Evesson FJ, Seto JT, Chiotis M, et al. (2008) Limb-girdle muscular dystrophy: diagnostic evaluation, frequency and clues to pathogenesis. Neuromuscul Disord 18: 34-44.
15. Piccolo F, Moore SA, Ford GC, Campbell KP, (2000) Intracellular accumulation and reduced sarcolemmal expression of dysferlin in limb-girdle muscular dystrophies. Ann Neurol 48: 902-912.
16. Tagawa K, Ogawa M, Kawabe K, Yamanaka G, Matsumura T, et al. (2003) Protein and gene analyses of dysferlinopathy in a large group of Japanese muscular dystrophy patients. J Neurol Sci 211: 23-28.
17. Saito A, Higuchi I, Nakagawa M, Saito M, Hirata K, et al. (2002) Miyoshi myopathy patients with novel 5′ splicing donor site mutations showed different dysferlin immunostaining at the sarcolemma. Acta Neuropathol 104: 615-620.
18. Rosales XQ, Gastier-Foster JM, Lewis S, Vinod M, Thrush DL, et al. (2010) Novel diagnostic features of dysferlinopathies. Muscle Nerve 42: 14-21.
19. Lennon NJ, Kho A, Bacskai BJ, Perlmutter SL, Hyman BT, et al. (2003) Dysferlin interacts with annexins A1 and A2 and mediates sarcolemmal wound-healing. J Biol Chem 278: 50466-50473.
20. Huang Y, de Morree A, van Remoortere A, Bushby K, Frants RR, et al. (2008) Calpain 3 is a modulator of the dysferlin protein complex in skeletal muscle. Hum Mol Genet 17: 1855-1866.
21. Huang Y, Verheesen P, Roussis A, Frankhuizen W, Ginjaar I, et al. (2005) Protein studies in dysferlinopathy patients using llama-derived antibody fragments selected by phage display. Eur J Hum Genet 13: 721-730.
22. Matsuda C, Hayashi YK, Ogawa M, Aoki M, Murayama K, et al. (2001) The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle. Hum Mol Genet 10: 1761-1766.
23. Huang Y, Laval SH, van Remoortere A, Baudier J, Benaud C, et al. (2007) AHNAK, a novel component of the dysferlin protein complex, redistributes to the cytoplasm with dysferlin during skeletal muscle regeneration. Faseb J 21: 732-742.
24. Matsuda C, Kameyama K, Tagawa K, Ogawa M, Suzuki A, et al. (2005) Dysferlin interacts with affixin (beta-parvin) at the sarcolemma. J Neuropathol Exp Neurol 64: 334-340.
25. Ampong BN, Imamura M, Matsumiya T, Yoshida M, Takeda S, (2005) Intracellular localization of dysferlin and its association with the dihydropyridine receptor. Acta Myol 24: 134-144.
26. Cai C, Weisleder N, Ko JK, Komazaki S, Sunada Y, et al. (2009) Membrane repair defects in muscular dystrophy are linked to altered interaction between MG53, caveolin-3, and dysferlin. J Biol Chem 284: 15894-15902.
27. Azakir BA, Di Fulvio S, Therrien C, Sinnreich M, (2010) Dysferlin interacts with tubulin and microtubules in mouse skeletal muscle. PLoS One 5: e10122.
28. Anderson LV, Harrison RM, Pogue R, Vafiadaki E, Pollitt C, et al. (2000) Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies). Neuromuscul Disord 10: 553-559.
29. Chrobakova T, Hermanova M, Kroupova I, Vondracek P, Marikova T, et al. (2004) Mutations in Czech LGMD2A patients revealed by analysis of calpain3 mRNA and their phenotypic outcome. Neuromuscul Disord 14: 659-665.
30. Hermanova M, Zapletalova E, Sedlackova J, Chrobakova T, Letocha O, et al. (2006) Analysis of histopathologic and molecular pathologic findings in Czech LGMD2A patients. Muscle Nerve 33: 424-432.
31. Cacciottolo M, Numitone G, Aurino S, Caserta IR, Fanin M, et al. (2011) Muscular dystrophy with marked Dysferlin deficiency is consistently caused by primary dysferlin gene mutations. Eur J Hum Genet.
32. Gallardo E, Rojas-Garcia R, de Luna N, Pou A, Brown RH Jr, et al. (2001) Inflammation in dysferlin myopathy: immunohistochemical characterization of 13 patients. Neurology 57: 2136-2138.
33. Spuler S, Carl M, Zabojszcza J, Straub V, Bushby K, et al. (2008) Dysferlin-deficient muscular dystrophy features amyloidosis. Ann Neurol 63: 323-328.
34. Rutgers KS, van Remoortere A, van Buchem MA, Verrips CT, Greenberg SM, et al. (2009) Differential recognition of vascular and parenchymal beta amyloid deposition. Neurobiol Aging.
35. De Luna N, Freixas A, Gallano P, Caselles L, Rojas-Garcia R, et al. (2007) Dysferlin expression in monocytes: a source of mRNA for mutation analysis. Neuromuscul Disord 17: 69-76.
36. De Luna N, Gallardo E, Illa I, (2004) In vivo and in vitro dysferlin expression in human muscle satellite cells. J Neuropathol Exp Neurol 63: 1104-1113.
37. Anderson LV, Davison K, (1999) Multiplex Western blotting system for the analysis of muscular dystrophy proteins. Am J Pathol 154: 1017-1022.
38. Paradas C, Fernandez-Cadenas I, Gallardo E, Llige D, Arenas J, et al. (2005) Variable presentation of the clinical phenotype of McArdle's disease in a kindred harbouring a novel compound genotype in the muscle glycogen phosphorylase gene. Neurosci Lett 391: 28-31.